オカザキ　ケン   KEN OKAZAKI   岡崎　賢    所属   医学部 医学科（東京女子医科大学病院）    職種   教授・基幹分野長
論文種別	症例報告
言語種別	英語
査読の有無	査読あり
表題	Anterior cruciate ligament reconstruction in a patient who has received systemic steroids for autoimmune disease.
掲載誌名	正式名：Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology 略　 称：Asia Pac J Sports Med Arthrosc Rehabil Technol ISSNコード：22146873/22146873
掲載区分	国外
巻・号・頁	11,pp.12-14
著者・共著者	Ushio Tetsuro, Okazaki Ken, Mizu-Uchi Hideki, Hamai Satoshi, Akasaki Yukio, Nakashima Yasuharu
担当区分	2nd著者,責任著者
発行年月	2018/01
概要	Background:An anterior cruciate ligament (ACL) reconstruction has become more common and the surgical morbidity has decreased, it has been performed not only in younger people to play sports but also middle-aged people, with satisfactory results. Therefore, some patients might have comorbidities for which they take medicines. Especially the medicines, such as systemic steroids, might influence the reconstructed ligament strength and durability.Case report:A 49-year-old woman who was taking oral steroids for autoimmune hepatitis suffered a spontaneous ACL injury. She complained of unstable symptoms in the knee despite initial conservative treatment. Then, she was treated operatively with autologous hamstring tendon grafts. Three years postoperatively, her knee remained stable with 1.8 mm side-to-side difference on a Kneelax arthrometer and with 1.6 mm on anterior stress radiographs. There was no rerupture or instability.Conclusion:The patient who had received systemic steroids for a long time recovered satisfactorily after the operation, with achievement of knee stability and possibility to prevent degenerative change in the knee joint. ACL reconstruction should be considered even in patients with such medication.
DOI	10.1016/j.asmart.2017.11.003
PMID	29552504